# The Cannabist Co. Exits Ohio and Delaware Amid Bankruptcy

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/multi-state-cannabis-operator-bankruptcies-patient-access/
> **Published:** 2026-03-24T18:04:38-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:40:25-04:00
> **Clinical Summary:** Explore how multi-state cannabis operator bankruptcies disrupt patient access and supply chains in Ohio, Delaware, and other states.

---

✦ New
CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely.
⚒ Cannabis News  |  CED Clinic
AccessIndustry[Patient Care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/)Supply Chain[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)

Why This Matters

Multi-state operator bankruptcies create immediate access disruptions for patients relying on specific products or consistent supply chains. When established dispensaries close or change ownership, patients may face interruptions in their therapeutic regimens, particularly those using precise dosing protocols for chronic conditions.

Clinical Summary
The Cannabist Co., a multi-state cannabis operator, has announced bankruptcy proceedings and asset sales across eight states including Ohio and Delaware. This represents another consolidation event in the [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/), where smaller and mid-tier operators face financial pressures from regulatory costs, taxation burdens, and market oversaturation. The closures will affect patient access to cannabis medicines in affected markets, though the specific timeline and transition plans for [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) remain unclear from available reporting.

Dr. Caplan’s Take

“I’ve seen patients struggle when their regular dispensary closes or changes hands—it’s not just about convenience, it’s about therapeutic continuity. Patients should identify backup sources now and document their current protocols before access becomes uncertain.”

Clinical Perspective
🧠 Patients in affected states should immediately identify alternative dispensaries and confirm product availability for their current regimens. Clinicians should help patients document their current cannabis protocols including specific products, dosing, and timing. This industry instability underscores the importance of having multiple access points and being prepared for supply chain disruptions in [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) care.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20The%20Cannabist%20Co.%20to%20Exit%20Ohio%2C%20Delaware%2C%20Sell%20Assets%20in%206%20Other%20States%2C%20Commenc...%20%40drcaplan&url=https%3A//www.cannabisbusinesstimes.com/finance/news/15820452/the-cannabist-co-to-exit-ohio-delaware-sell-assets-in-6-other-states-commence-bankruptcy-proceedings)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.cannabisbusinesstimes.com/finance/news/15820452/the-cannabist-co-to-exit-ohio-delaware-sell-assets-in-6-other-states-commence-bankruptcy-proceedings)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20The%20Cannabist%20Co.%20to%20Exit%20Ohio%2C%20Delaware%2C%20Sell%20Assets%20in%206%20Other%20States%2C%20Commenc...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.cannabisbusinesstimes.com/finance/news/15820452/the-cannabist-co-to-exit-ohio-delaware-sell-assets-in-6-other-states-commence-bankruptcy-proceedings)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

📰 Source: [https://www.cannabisbusinesstimes.com/finance/news/15820452/the-cannabist-co-to-exit-ohio-delaware-sell-assets-in-6-other-states-commence-bankruptcy-proceedings](https://www.cannabisbusinesstimes.com/finance/news/15820452/the-cannabist-co-to-exit-ohio-delaware-sell-assets-in-6-other-states-commence-bankruptcy-proceedings)

Table of Contents

- [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news)
- [What key areas does this cannabis news cover?](#What_key_areas_does_this_cannabis_news_cover)
- [Why is this cannabis news considered clinically relevant?](#Why_is_this_cannabis_news_considered_clinically_relevant)
- [What type of healthcare professionals should pay attention to this news?](#What_type_of_healthcare_professionals_should_pay_attention_to_this_news)
- [How does this news impact the medical cannabis industry?](#How_does_this_news_impact_the_medical_cannabis_industry)
- [Related](#Related)

## FAQ

#### What is the clinical relevance rating of this cannabis news?

This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This classification means the findings or policy developments are emerging and worth monitoring closely by healthcare professionals.

#### What key areas does this cannabis news cover?

The article covers multiple important aspects of medical cannabis including patient access, industry developments, patient care considerations, and supply chain issues. These tags indicate comprehensive coverage of the medical cannabis ecosystem.

#### Why is this cannabis news considered clinically relevant?

The content is classified as having notable clinical interest because it contains emerging findings or policy developments in the cannabis field. Healthcare providers should monitor these developments as they may impact patient care and treatment options.

#### What type of healthcare professionals should pay attention to this news?

This news is particularly relevant for clinicians working in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/), [pain management](https://cedclinic.com/cbd-cbg-topicals-for-eczema/), and other specialties that may prescribe or recommend medical cannabis. The clinical relevance rating suggests it’s important for staying current with cannabis-related healthcare developments.

#### How does this news impact the medical cannabis industry?

Given the industry and supply chain tags, this news likely addresses significant changes or developments affecting how medical cannabis is produced, distributed, or accessed by patients. These changes could influence treatment availability and patient outcomes.

{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “The Cannabist Co. to Exit Ohio, Delaware, Sell Assets in 6 Other States, Commence …”, “url”: “https://www.cannabisbusinesstimes.com/finance/news/15820452/the-cannabist-co-to-exit-ohio-delaware-sell-assets-in-6-other-states-commence-bankruptcy-proceedings”, “datePublished”: “2026-03-24T18:35:12Z”, “about”: “cannabist co exit ohio delaware sell”}

RELATED READING AT CED CLINIC

Continue exploring the evidence

[The Cannabist Company Declares Bankruptcy, Sells Assets Across Multiple States](https://cedclinic.com/2026-cannabis-industry-consolidation-bankruptcy-impact/)

Detailed coverage of The Cannabist Company's bankruptcy and asset sales impacting multiple state markets.

[Read More](https://cedclinic.com/2026-cannabis-industry-consolidation-bankruptcy-impact/)

Mass Layoff as Cannabis MSO PharmaCann Exits Colorado Market – MJBizDaily

Insights into PharmaCann's exit from Colorado and its implications for the [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) workforce.

Learn More

[New Ohio Restrictions On Marijuana And Hemp THC Products Take Effect After Referendum](https://cedclinic.com/ohio-hemp-thc-regulations-impact-medical-cannabis-access/)

Overview of recent regulatory changes in Ohio affecting marijuana and hemp THC products post-referendum.

[Explore Details](https://cedclinic.com/ohio-hemp-thc-regulations-impact-medical-cannabis-access/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).